Exactech Broadens Spine Portfolio with Launch of Anchored Anterior Cervical Interbody Device at NASS 2015
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the launch of the new Acapella® One Cervical Spacer System with integrated anchors during the North American Spine Society Annual Meeting (NASS) in Chicago, IL, this week. Exactech will feature an educational exhibit, booth #1033, during the meeting.
“Exactech is focused on providing a simplified technique for surgeons and the potential for reduced operating time for patients”Tweet this
With the introduction of Acapella One, a cervical cage with integrated anchors, surgeons can restore disc height while providing integrated fixation to prevent device migration during anterior cervical spinal fusions. The unique design of the cage allows for single-step deployment of both the integrated anchors simultaneously, therefore simplifying the overall procedure.
After completing the first surgery, Anders Cohen, DO said, “I have been very pleased with my initial clinical results using the Acapella One cage. We all agreed that it was important to design an implant that would be simple to implant at any level, and it accomplished that goal today.”
Exactech designed the Acapella system in collaboration with a surgeon team including Dr. Cohen, Steven Bailey, MD and Troy Trimble, DO. Together, they created simplified instrumentation designed to minimize surgical time and instrument processing. The system includes a wide range of sizes to accommodate the patient’s own unique anatomy. The device comes in two footprints, three sagittal profiles and six heights for more than 36 size combinations.
"Exactech is focused on providing a simplified technique for surgeons and the potential for reduced operating time for patients," said Bruce Thompson, Sr. Vice President and General Manager of Spine and Biologics at Exactech. “We are pleased with the early results reported with Acapella One, which we believe will deliver on both of these goals.”
The successful pilot launch of Acapella One marks another milestone in the continued development of innovative products by Exactech Spine. The system rounds out Exactech’s anterior cervical offerings, including the newly released Ambassador™ Cervical plate, which surgeons a wide range of options for performing cervical fusion. Surgeons can learn more about the Exactech Spine atwww.ExactechSpine.com.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at
An investment profile on Exactech may be found at
To receive future releases in e-mail alerts, sign up at
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Jody Phillips, 352-377-1140
Executive Vice President of Finance & Chief Financial Officer
Julie Marshall or Frank Hawkins, 305-451-1888
Priscilla Bennett, 352-377-1140
Vice President, Corporate & Marketing Communicatio
Published at BusinessWire